Association between symptomatic profile and remission following antidepressant treatment in unipolar major depression

dc.contributor.authorNavarro, Valentín
dc.contributor.authorGonzález, Alejandro
dc.contributor.authorGuarch, Joana
dc.contributor.authorPenadés Rubio, Rafael
dc.contributor.authorTorra, Mercè
dc.contributor.authorFañanás Saura, Lourdes
dc.contributor.authorArias Sampériz, Bárbara
dc.contributor.authorSerra, Maria
dc.contributor.authorPintor Pérez, Luis
dc.contributor.authorGastó Ferrer, Cristóbal
dc.date.accessioned2026-07-10T10:20:37Z
dc.date.available2026-07-10T10:20:37Z
dc.date.issued2013
dc.date.updated2026-07-10T10:20:38Z
dc.description.abstractBackground: To evaluate, in patients affected by an acute major depressive episode, what predictive value certain baseline psychopathological characteristics have with regard to expected therapeutic remission following biological antidepressant treatment (pharmacological/electroconvulsive; non-psychological). Methods: Six predefined psychopathological characteristics in acute major depressive episode were evaluated using a logistic regression model through a protocolised antidepressant treatment to assess their predictive value with regard to expected remission rate. Results: The final study sample consisted of 129 subjects affected by an acute major depressive episode. From the baseline evaluation of the anguish/restlessness, reduced emotional reactivity, reduced attention, reduced motor response, feeling of worthlessness, and mood characteristics items, it was possible to correctly classify 88.1% of the sample as remitter/non-remitter with sensitivity of 0.77 and specificity of 0.96. Addition of the 17-item HRSD baseline variable to the regression model increased the capacity for correct classification of the baseline sample by only 0.09%. Limitations: Protocolised antidepressant treatment was used. The results of this study may not be generalisable to pharmacological treatments not included in this protocol. Conclusions: The results of this study suggest that certain baseline psychopathological characteristics (and perhaps other clinical variables too) of the acute major depressive episode may be of great use in establishing patient subgroups according to expected clinical remission to the administration of biological antidepressant treatment. This could have considerable consequences for individualised therapeutic decision-making and for future researches (clinical trials included).
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec624969
dc.identifier.issn0165-0327
dc.identifier.pmid23623741
dc.identifier.urihttps://hdl.handle.net/2445/230591
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.jad.2013.03.025
dc.relation.ispartofJournal of Affective Disorders, 2013, vol. 150, num.2, p. 209-215
dc.relation.urihttps://doi.org/10.1016/j.jad.2013.03.025
dc.rights(c) Elsevier B.V., 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Biologia Evolutiva, Ecologia i Ciències Ambientals)
dc.subject.classificationDepressió psíquica
dc.subject.classificationAntidepressius
dc.subject.classificationTrastorn bipolar
dc.subject.otherMental depression
dc.subject.otherAntidepressants
dc.subject.otherManic-depressive illness
dc.titleAssociation between symptomatic profile and remission following antidepressant treatment in unipolar major depression
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
163774.pdf
Mida:
401.87 KB
Format:
Adobe Portable Document Format